22 min listen
Episode 221: ASCO GU 2023: Matt Galsky, MD Gives an Update on the CheckMate 274 Trial
FromThe Uromigos
Episode 221: ASCO GU 2023: Matt Galsky, MD Gives an Update on the CheckMate 274 Trial
FromThe Uromigos
ratings:
Length:
30 minutes
Released:
Feb 17, 2023
Format:
Podcast episode
Description
Matt Galsky, MD discusses several abstracts presented at the 2023 ASCO GU Cancers Symposium on perioperative nivolumab for urothelial cancer, including an update on the CheckMate 274 trial that examined adjuvant nivolumab versus placebo in patients with high-risk muscle invasive urothelial cancer after radical surgery. Dr. Galsky is the Director of Genitourinary Medical Oncology at The Tisch Cancer Institute and Professor of Medicine at the Icahn School of Medicine at Mount Sinai.
Released:
Feb 17, 2023
Format:
Podcast episode
Titles in the series (100)
Episode 8: COVID-19 and Cancer Patients by The Uromigos